adenosine has been researched along with Brain Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bekas, N; Christoforidou, G; Dafou, D; Kanata, E; Karagianni, K; Pettas, S; Sklaviadis, T; Xanthopoulos, K | 1 |
| Chang, R; Huang, Z; Li, Y; Tan, S; Zhao, S; Zou, J | 1 |
| Fathalla, AM; Moustafa, AA; Soliman, AM | 1 |
| Lopes, LV; Ribeiro, JA; Sebastião, AM | 1 |
| Boison, D | 2 |
| de Mendonça, A; Ribeiro, JA; Sebastião, AM | 1 |
| Fatokun, AA; Smith, RA; Stone, TW | 1 |
| Chen, JF; de Mendonça, A; Domenici, MR; Geiger, J; Lopes, LV; Melani, A; Pedata, F; Popoli, P; Sonsalla, PK | 1 |
| Benarroch, EE | 1 |
| Beenhakker, M; Carter, MF; Jacobson, KA; Lin, RC; von Lubitz, DK | 1 |
| Gash, DM; Levivier, M; Przedborski, S | 1 |
| Adami, M; Bertorelli, R; Ferri, C; Ongini, E | 1 |
| Furukawa, Y; Machigashira, N; Maruyama, Y; Matsuzaki, T; Nomoto, M; Osame, M; Une, F; Utatsu, Y; Yoshida, Y | 1 |
| Jenkins, CS; Oosterhuis, H; Prenger, D; ten Cate, JW; Vos, J | 1 |
| Pinard, E; Puiroud, S; Seylaz, J | 1 |
| Wieloch, T | 1 |
| Weiss, HJ | 1 |
12 review(s) available for adenosine and Brain Disorders
| Article | Year |
|---|---|
A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations.
Topics: Adenosine; Adenosine Deaminase; Animals; Brain; Brain Diseases; Mammals; Neurodegenerative Diseases; RNA; RNA Editing | 2022 |
Emerging Roles of FTO in Neuropsychiatric Disorders.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Brain Diseases; Humans; Mental Disorders; Obesity; RNA, Messenger | 2022 |
Adenosine role in brain functions: Pathophysiological influence on Parkinson's disease and other brain disorders.
Topics: Adenosine; Brain Diseases; Caffeine; Dopamine; Humans; Parkinson Disease | 2018 |
Adenosine and related drugs in brain diseases: present and future in clinical trials.
Topics: Adenosine; Animals; Astrocytes; Brain; Brain Diseases; Clinical Trials as Topic; Cognition; Forecasting; Humans; Memory; Mice; Mice, Knockout; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptor, Adenosine A1; Receptor, Adenosine A2A; Schizophrenia; Substance-Related Disorders | 2011 |
Modulators of nucleoside metabolism in the therapy of brain diseases.
Topics: Adenosine; Adenosine Kinase; Analgesics; Animals; Anticonvulsants; Brain; Brain Diseases; Epilepsy; Gene Expression; Humans; Metabolic Networks and Pathways; Mice; Mice, Knockout; Neuroprotective Agents; Pain; Protein Kinase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptor, Adenosine A1; Receptor, Adenosine A2A; Schizophrenia; Signal Transduction; Sleep Wake Disorders | 2011 |
Adenosine receptors in the nervous system: pathophysiological implications.
Topics: Adenosine; Brain Diseases; Homeostasis; Humans; Nervous System; Neurons; Receptors, Purinergic P1 | 2002 |
Adenosine as a neuromodulator in neurological diseases.
Topics: Adenosine; Adenosine Kinase; Alzheimer Disease; Animals; Brain Diseases; Brain Ischemia; Epilepsy; Humans; Huntington Disease; Pain; Parkinson Disease; Schizophrenia; Synaptic Transmission | 2008 |
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
Topics: Adenosine; Animals; Brain; Brain Diseases; Brain Injury, Chronic; Cell Survival; Cytoprotection; Humans; Nerve Degeneration; Neuroprotective Agents; Receptor, Adenosine A2A | 2007 |
Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease.
Topics: Adenosine; Animals; Brain Diseases; Central Nervous System; Extracellular Space; Humans; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Xanthines | 2008 |
Adenosine: a prototherapeutic concept in neurodegeneration.
Topics: Adenosine; Animals; Brain; Brain Diseases; Glutamic Acid; Humans; Nerve Degeneration; Neuroprotective Agents; Receptors, Purinergic P1; Stress, Physiological | 1995 |
Adenosine A2A receptors and neuroprotection.
Topics: Adenosine; Animals; Brain; Brain Diseases; Brain Ischemia; Dopamine; Humans; Neuroprotective Agents; Parkinson Disease; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Seizures | 1997 |
Neurochemical correlates to selective neuronal vulnerability.
Topics: Adenosine; Afferent Pathways; Animals; Aspartic Acid; Brain Diseases; Brain Ischemia; Calcium; Chlorides; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hypoglycemia; Models, Biological; Neural Inhibition; Neurochemistry; Neurons; Neurotransmitter Agents; Norepinephrine; Parasympathomimetics; Quinolinic Acid; Quinolinic Acids; Rats | 1985 |
6 other study(ies) available for adenosine and Brain Disorders
| Article | Year |
|---|---|
Cell death in rat cerebellar granule neurons induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Animals, Newborn; Apoptosis; Brain Diseases; Catalase; Cell Death; Cell Survival; Cells, Cultured; Cerebellar Cortex; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Necrosis; Neurons; Oxidative Stress; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P1; Time Factors; Triazines; Triazoles | 2007 |
Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
Topics: Adenosine; Animals; Autoradiography; Benzazepines; Brain Diseases; Corpus Striatum; Electron Transport Complex IV; Fetal Tissue Transplantation; Isoquinolines; Male; Nerve Tissue; Phenethylamines; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, GABA-A; Receptors, Purinergic P1; Time Factors | 1995 |
Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Brain Diseases; Cell Count; Cerebrospinal Fluid; Female; Glucose; Humans; Male; Middle Aged; Neopterin; Prognosis; Severity of Illness Index | 1999 |
Spontaneous platelet aggregation in cerebrovascular disease.
Topics: Adenosine; Adenosine Diphosphate; Adult; Aged; Aspirin; Blindness; Brain Diseases; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Paresthesia; Phentolamine; Platelet Aggregation | 1978 |
Role of adenosine in cerebral hypoxic hyperemia in the unanesthetized rabbit.
Topics: Adenosine; Animals; Brain Diseases; Caudate Nucleus; Cerebrovascular Circulation; Hippocampus; Hyperemia; Male; Rabbits; Thalamus | 1989 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrine; Glomerulonephritis; Heart Valve Prosthesis; Humans; Hypertension, Malignant; Ischemia; Myocardial Infarction; Platelet Adhesiveness; Postoperative Complications; Prostaglandins; Pyrimidines; Thromboembolism; Thrombophlebitis; Thrombosis; Xanthines | 1974 |